NCT06492460View on ClinicalTrials.gov

2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

422

Participants

Timeline

Start Date

September 20, 2024

Primary Completion Date

September 20, 2029

Study Completion Date

July 17, 2033

Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
DRUG

Drug：Cisplatin

Concurrent Cisplatin chemotherapy (100 mg/m2 intravenous injection,once every 3 weeks, twice in total, on days 1 and 22) will be given plus intensity modulated radiotherapy

Trial Locations (5)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

Unknown

NOT_YET_RECRUITING

Affiliated Hospital of Guilin Medical College, Guilin

NOT_YET_RECRUITING

Hunan Cancer Hospital, Changsha

NOT_YET_RECRUITING

Xiangya Hospital, Central South University, Changsha

NOT_YET_RECRUITING

Jiangsu Cancer Hospital, Nanjing

All Listed Sponsors
collaborator

Hunan Cancer Hospital

OTHER

collaborator

Guilin Medical University, China

OTHER

collaborator

Jiangsu Cancer Institute & Hospital

OTHER

collaborator

Xiangya Hospital of Central South University

OTHER

lead

Sun Yat-sen University

OTHER